Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Haber

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Nature Medicine|August 10, 2000
Will radioiodine be useful in treatment of breast cancer?G H Daniels, D A Haber
Cell|January 11, 1991
Rate-limiting steps: the genetics of pediatric cancersD A Haber, D E Housman
Nucleic Acids Research|December 11, 1989
MspI/HpaII polymorphism in the human multidrug resistance gene 1D A Haber, D E Housman
Seminars in Oncology|April 1, 1988
Primary gastrointestinal lymphomaD A Haber, R J Mayer
The New Biologist|February 1, 1992
WT1: a novel tumor suppressor gene inactivated in Wilms' tumorD A Haber, A J Buckler
Lancet (London, England)|June 2, 1998
The promise of cancer geneticsD A Haber, E R Fearon
Cell|November 1, 1981
Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomesD A Haber, R T Schimke
Annual Review of Medicine|March 24, 1998
Hereditary breast cancerL W Ellisen, D A Haber
Medical and Pediatric Oncology|November 1, 1996
Functional properties of WT1D A Haber, C Englert, S Maheswaran
British Journal of Cancer|September 18, 2008
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2S Kim, G Mohapatra, D A Haber
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Nature Medicine|August 10, 2000
Will radioiodine be useful in treatment of breast cancer?G H Daniels, D A Haber
Cell|January 11, 1991
Rate-limiting steps: the genetics of pediatric cancersD A Haber, D E Housman
Nucleic Acids Research|December 11, 1989
MspI/HpaII polymorphism in the human multidrug resistance gene 1D A Haber, D E Housman
Seminars in Oncology|April 1, 1988
Primary gastrointestinal lymphomaD A Haber, R J Mayer
The New Biologist|February 1, 1992
WT1: a novel tumor suppressor gene inactivated in Wilms' tumorD A Haber, A J Buckler
Lancet (London, England)|June 2, 1998
The promise of cancer geneticsD A Haber, E R Fearon
Cell|November 1, 1981
Unstable amplification of an altered dihydrofolate reductase gene associated with double-minute chromosomesD A Haber, R T Schimke
Annual Review of Medicine|March 24, 1998
Hereditary breast cancerL W Ellisen, D A Haber
Medical and Pediatric Oncology|November 1, 1996
Functional properties of WT1D A Haber, C Englert, S Maheswaran
British Journal of Cancer|September 18, 2008
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2S Kim, G Mohapatra, D A Haber
Pageof 9